US 8957078
Compounds useful as inhibitors of ATR kinase
granted A61KA61K31/36A61K31/4188
Quick answer
US patent 8957078 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 82
- CPC classes
- A61K, A61K31/36, A61K31/4188, A61K31/519, A61K31/5377